Sales & Marketing News | pharmaphorum

News

CVS Health launches private label biosimilars unit

CVS Health has made a move on the US biosimilars category with the launch of Cordavis, a new business unit that will work with other drugmakers to bring private-label bios

News

First Tysabri biosimilar cleared by FDA for MS

Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overc

News

Changing Faces: Pharma supplier hires from July 2023

In our second hires round-up for the month of July, we look at hires in pharma-adjacent industries like CROs, CDMOs, med device, and digital health.

News

Mallinckrodt looking at a second bankruptcy filing

Mallinckrodt is facing the prospect of a second bankruptcy filing in the space of three years, as it struggles to get its business back on track and meet the requirement o

News

BMS backs $255m round for contract cell maker Cellares

Cellares has just closed a major $255 million third-round financing that will be used to complete a highly automated facility in New Jersey for the production of cell ther

News

Bayer's digital drive in consumer health gathers pace

Earlier this year, Bayer formed a new business unit that promised to shake up the consumer health category with a new personalised approach driven by digital technologies.

CVS Health launches private label biosimilars unit

First Tysabri biosimilar cleared by FDA for MS

Changing Faces: Pharma supplier hires from July 2023

Mallinckrodt looking at a second bankruptcy filing

BMS backs $255m round for contract cell maker Cellares

Bayer's digital drive in consumer health gathers pace

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks